Hidehito Horinouchi/X
Mar 4, 2025, 09:25
Hidehito Horinouchi: Oral – Lung / Thoracic Cancer 1
Hidehito Horinouchi, Assistant Chief of the National Cancer Center Hospital, shared a post on X:
“Oral: Lung / Thoracic Cancer 1
Chairs: Drs. Makoto Nishio, Nobuyuki Yamamoto.
1st Line ICI in KRASm.
Resistance to Alectinib.
MARIPOSA trial.
Zonbertinib / Beamion Lung-1.
Firmonertinib / Read FURTHER.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jun 5, 2025, 02:37
Jun 5, 2025, 02:29
Jun 5, 2025, 02:25
Jun 5, 2025, 02:05
Jun 5, 2025, 01:56
Jun 5, 2025, 01:54